Cervical Cancer

Cancer Screening System Clinical Trial in China Commenced

Published in Women's Health Weekly, January 25th, 2001

Ampersand Medical Corp. (AMPM), Chicago, Illinois, announced the commencement of a clinical trial in China using the InPath System, a screening system for cervical cancer.

The trial is the first step in a larger effort to evaluate the efficacy of the InPath System for cervical-cancer screening. Principal investigators for the study include researchers from the Cleveland Clinic Foundation, the Chinese Academy of Medical Sciences, and Kaiser Permanente.

The InPath System is based on the use of biomolecular markers with fluorescent tags to identify abnormal cervical cells. This screening technology includes the use of multiple protein-based probes and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (2001-01-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry